- 专利标题: Gene editing through microfluidic delivery
-
申请号: US15542892申请日: 2016-01-12
-
公开(公告)号: US11125739B2公开(公告)日: 2021-09-21
- 发明人: Armon R. Sharei , Marc Lajoie , Klavs F. Jensen , Robert S. Langer
- 申请人: Massachusetts Institute of Technology , President and Fellows of Harvard College
- 申请人地址: US MA Cambridge; US MA Cambridge
- 专利权人: Massachusetts Institute of Technology,President and Fellows of Harvard College
- 当前专利权人: Massachusetts Institute of Technology,President and Fellows of Harvard College
- 当前专利权人地址: US MA Cambridge; US MA Cambridge
- 代理机构: Wolf, Greenfield & Sacks, P.C.
- 国际申请: PCT/US2016/013113 WO 20160112
- 国际公布: WO2016/115179 WO 20160721
- 主分类号: C12N15/87
- IPC分类号: C12N15/87 ; G01N33/50 ; G01N33/487 ; C12Q1/00
摘要:
Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described. The methods and systems of the invention solve the problem of intracellular delivery of gene editing components and gene editing complexes to target cells. The results described herein indicate that delivery of gene editing components, e.g., protein, ribonucleic acid (RNA), and deoxyribonucleic acid (DNA), by mechanical disruption of cell membranes leads to successful gene editing. Because intracellular delivery of gene editing materials is a current challenge, the methods provide a robust mechanism to engineer target cells without the use of potentially harmful viral vectors or electric fields.
公开/授权文献
- US20180003696A1 GENE EDITING THROUGH MICROFLUIDIC DELIVERY 公开/授权日:2018-01-04
信息查询
IPC分类: